Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Oncolytics Biotech Inc T.ONC

Alternate Symbol(s):  ONCY

Oncolytics Biotech Inc. is a biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to phase 3 licensure-enabling studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.


TSX:ONC - Post by User

Post by inthnoon Aug 09, 2023 11:02am
244 Views
Post# 35579522

onc price doesn't matter

onc price doesn't matter
According to some price doesn't matter but tell that to all of the shareholders when onc was trading at 4.29 less than a month ago. Price does not matter maybe when it comes to a buyout but I do not think that is off the table or the bought deal would not have been done....Maybe a partnership but that even seems tentative right now. Hopefully some clarification tomorrow and next week and then after the 90 days and then after ESMO and then after OS resutls and then eventually....Hey, just having a moment. Been in this for over 20 years and seen similar financings and then the support drops off and the sp speaks for itself and hoping that this time will be different and that the financing was actually done for a reason that will make a difference for all concerned.
2023-07-10 T ONC 4.05 4.40 4.05 4.29 0.22    
 

<< Previous
Bullboard Posts
Next >>